Literature DB >> 23183282

A randomized trial of varenicline (chantix) for the treatment of spinocerebellar ataxia type 3.

Barbara S Connolly, L K Prashanth, Binit B Shah, Connie Marras, Anthony E Lang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23183282     DOI： 10.1212/WNL.0b013e318278a059

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

Review 1.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

2.  Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.

Authors:  Jan Cendelin; Marija Cvetanovic; Mandi Gandelman; Hirokazu Hirai; Harry T Orr; Stefan M Pulst; Michael Strupp; Filip Tichanek; Jan Tuma; Mario Manto
Journal:  Cerebellum       Date:  2021-08-10       Impact factor: 3.648

3.  Consensus paper: management of degenerative cerebellar disorders.

Authors:  W Ilg; A J Bastian; S Boesch; R G Burciu; P Celnik; J Claaßen; K Feil; R Kalla; I Miyai; W Nachbauer; L Schöls; M Strupp; M Synofzik; J Teufel; D Timmann
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847

Review 4.  Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.

Authors:  Maryka Quik; Danhui Zhang; Xiomara A Perez; Tanuja Bordia
Journal:  Pharmacol Ther       Date:  2014-05-14       Impact factor: 12.310

Review 5.  Treatment Options in Degenerative Cerebellar Ataxia: A Systematic Review.

Authors:  Harini Sarva; Vicki Lynn Shanker
Journal:  Mov Disord Clin Pract       Date:  2014-06-12

6.  Nine-hole Peg Test and Ten-meter Walk Test for Evaluating Functional Loss in Chinese Charcot-Marie-Tooth Disease.

Authors:  Hui-Xia Niu; Rui-Hao Wang; Hong-Liang Xu; Bo Song; Jing Yang; Chang-He Shi; Yu-Sheng Li; Bing-Qian Zhang; Shao-Ping Wang; Quan Yong; Yuan-Yuan Wang; Yu-Ming Xu
Journal:  Chin Med J (Engl)       Date:  2017-08-05       Impact factor: 2.628

Review 7.  Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado-Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies.

Authors:  Yu-Shuan Chen; Zhen-Xiang Hong; Shinn-Zong Lin; Horng-Jyh Harn
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.